Global Treatments for Alpha-1 Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301030009 | Category: Pharma & Healthcare | Pages: 100 | Format: PDF | Published Date: January 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Treatments for Alpha-1 market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Treatments for Alpha-1 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Indication and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Treatments for Alpha-1 market size and forecasts, in consumption value ($ Million), 2018-2029
Global Treatments for Alpha-1 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Treatments for Alpha-1 market size and forecasts, by Indication and by Application, in consumption value ($ Million), 2018-2029
Global Treatments for Alpha-1 market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Treatments for Alpha-1
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Treatments for Alpha-1 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim and Teva Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Treatments for Alpha-1 market is split by Indication and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Indication and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Indication
    Augmentation Therapy
    Cystic Fibrosis(CF)
    Non-CF Bronchiectasis(NCFB)
    Diabetes
    Other
Market segment by Application
    Hospitals
    Specialty Clinics
    Pharmacies
Market segment by players, this report covers
    Pfizer
    GlaxoSmithKline
    AstraZeneca
    Boehringer Ingelheim
    Teva Pharmaceutical Industries
    Takeda
    Baxter
    Grifols
    CSL Behring
    Kamada Ltd
    Chiesi Pharmaceuticals
    Kedrion Group
    Vertex Pharmaceuticals
    ProMetic Life Sciences
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Treatments for Alpha-1 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Treatments for Alpha-1, with revenue, gross margin and global market share of Treatments for Alpha-1 from 2018 to 2023.
Chapter 3, the Treatments for Alpha-1 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Indication and application, with consumption value and growth rate by Indication, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Treatments for Alpha-1 market forecast, by regions, indication and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Treatments for Alpha-1.
Chapter 13, to describe Treatments for Alpha-1 research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Treatments for Alpha-1
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Treatments for Alpha-1 by Indication
        1.3.1 Overview: Global Treatments for Alpha-1 Market Size by Indication: 2018 Versus 2022 Versus 2029
        1.3.2 Global Treatments for Alpha-1 Consumption Value Market Share by Indication in 2022
        1.3.3 Augmentation Therapy
        1.3.4 Cystic Fibrosis(CF)
        1.3.5 Non-CF Bronchiectasis(NCFB)
        1.3.6 Diabetes
        1.3.7 Other
    1.4 Global Treatments for Alpha-1 Market by Application
        1.4.1 Overview: Global Treatments for Alpha-1 Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Specialty Clinics
        1.4.4 Pharmacies
    1.5 Global Treatments for Alpha-1 Market Size & Forecast
    1.6 Global Treatments for Alpha-1 Market Size and Forecast by Region
        1.6.1 Global Treatments for Alpha-1 Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Treatments for Alpha-1 Market Size by Region, (2018-2029)
        1.6.3 North America Treatments for Alpha-1 Market Size and Prospect (2018-2029)
        1.6.4 Europe Treatments for Alpha-1 Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Treatments for Alpha-1 Market Size and Prospect (2018-2029)
        1.6.6 South America Treatments for Alpha-1 Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Treatments for Alpha-1 Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Treatments for Alpha-1 Product and Solutions
        2.1.4 Pfizer Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 GlaxoSmithKline
        2.2.1 GlaxoSmithKline Details
        2.2.2 GlaxoSmithKline Major Business
        2.2.3 GlaxoSmithKline Treatments for Alpha-1 Product and Solutions
        2.2.4 GlaxoSmithKline Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GlaxoSmithKline Recent Developments and Future Plans
    2.3 AstraZeneca
        2.3.1 AstraZeneca Details
        2.3.2 AstraZeneca Major Business
        2.3.3 AstraZeneca Treatments for Alpha-1 Product and Solutions
        2.3.4 AstraZeneca Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 AstraZeneca Recent Developments and Future Plans
    2.4 Boehringer Ingelheim
        2.4.1 Boehringer Ingelheim Details
        2.4.2 Boehringer Ingelheim Major Business
        2.4.3 Boehringer Ingelheim Treatments for Alpha-1 Product and Solutions
        2.4.4 Boehringer Ingelheim Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.5 Teva Pharmaceutical Industries
        2.5.1 Teva Pharmaceutical Industries Details
        2.5.2 Teva Pharmaceutical Industries Major Business
        2.5.3 Teva Pharmaceutical Industries Treatments for Alpha-1 Product and Solutions
        2.5.4 Teva Pharmaceutical Industries Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
    2.6 Takeda
        2.6.1 Takeda Details
        2.6.2 Takeda Major Business
        2.6.3 Takeda Treatments for Alpha-1 Product and Solutions
        2.6.4 Takeda Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Takeda Recent Developments and Future Plans
    2.7 Baxter
        2.7.1 Baxter Details
        2.7.2 Baxter Major Business
        2.7.3 Baxter Treatments for Alpha-1 Product and Solutions
        2.7.4 Baxter Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Baxter Recent Developments and Future Plans
    2.8 Grifols
        2.8.1 Grifols Details
        2.8.2 Grifols Major Business
        2.8.3 Grifols Treatments for Alpha-1 Product and Solutions
        2.8.4 Grifols Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Grifols Recent Developments and Future Plans
    2.9 CSL Behring
        2.9.1 CSL Behring Details
        2.9.2 CSL Behring Major Business
        2.9.3 CSL Behring Treatments for Alpha-1 Product and Solutions
        2.9.4 CSL Behring Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 CSL Behring Recent Developments and Future Plans
    2.10 Kamada Ltd 
        2.10.1 Kamada Ltd Details
        2.10.2 Kamada Ltd Major Business
        2.10.3 Kamada Ltd Treatments for Alpha-1 Product and Solutions
        2.10.4 Kamada Ltd Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Kamada Ltd Recent Developments and Future Plans
    2.11 Chiesi Pharmaceuticals
        2.11.1 Chiesi Pharmaceuticals Details
        2.11.2 Chiesi Pharmaceuticals Major Business
        2.11.3 Chiesi Pharmaceuticals Treatments for Alpha-1 Product and Solutions
        2.11.4 Chiesi Pharmaceuticals Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Chiesi Pharmaceuticals Recent Developments and Future Plans
    2.12 Kedrion Group
        2.12.1 Kedrion Group Details
        2.12.2 Kedrion Group Major Business
        2.12.3 Kedrion Group Treatments for Alpha-1 Product and Solutions
        2.12.4 Kedrion Group Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Kedrion Group Recent Developments and Future Plans
    2.13 Vertex Pharmaceuticals
        2.13.1 Vertex Pharmaceuticals Details
        2.13.2 Vertex Pharmaceuticals Major Business
        2.13.3 Vertex Pharmaceuticals Treatments for Alpha-1 Product and Solutions
        2.13.4 Vertex Pharmaceuticals Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Vertex Pharmaceuticals Recent Developments and Future Plans
    2.14 ProMetic Life Sciences
        2.14.1 ProMetic Life Sciences Details
        2.14.2 ProMetic Life Sciences Major Business
        2.14.3 ProMetic Life Sciences Treatments for Alpha-1 Product and Solutions
        2.14.4 ProMetic Life Sciences Treatments for Alpha-1 Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 ProMetic Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Treatments for Alpha-1 Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Treatments for Alpha-1 by Company Revenue
        3.2.2 Top 3 Treatments for Alpha-1 Players Market Share in 2022
        3.2.3 Top 6 Treatments for Alpha-1 Players Market Share in 2022
    3.3 Treatments for Alpha-1 Market: Overall Company Footprint Analysis
        3.3.1 Treatments for Alpha-1 Market: Region Footprint
        3.3.2 Treatments for Alpha-1 Market: Company Product Type Footprint
        3.3.3 Treatments for Alpha-1 Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Indication
    4.1 Global Treatments for Alpha-1 Consumption Value and Market Share by Indication (2018-2023)
    4.2 Global Treatments for Alpha-1 Market Forecast by Indication (2024-2029)
5 Market Size Segment by Application
    5.1 Global Treatments for Alpha-1 Consumption Value Market Share by Application (2018-2023)
    5.2 Global Treatments for Alpha-1 Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Treatments for Alpha-1 Consumption Value by Indication (2018-2029)
    6.2 North America Treatments for Alpha-1 Consumption Value by Application (2018-2029)
    6.3 North America Treatments for Alpha-1 Market Size by Country
        6.3.1 North America Treatments for Alpha-1 Consumption Value by Country (2018-2029)
        6.3.2 United States Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        6.3.3 Canada Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        6.3.4 Mexico Treatments for Alpha-1 Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Treatments for Alpha-1 Consumption Value by Indication (2018-2029)
    7.2 Europe Treatments for Alpha-1 Consumption Value by Application (2018-2029)
    7.3 Europe Treatments for Alpha-1 Market Size by Country
        7.3.1 Europe Treatments for Alpha-1 Consumption Value by Country (2018-2029)
        7.3.2 Germany Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        7.3.3 France Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        7.3.5 Russia Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        7.3.6 Italy Treatments for Alpha-1 Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Treatments for Alpha-1 Consumption Value by Indication (2018-2029)
    8.2 Asia-Pacific Treatments for Alpha-1 Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Treatments for Alpha-1 Market Size by Region
        8.3.1 Asia-Pacific Treatments for Alpha-1 Consumption Value by Region (2018-2029)
        8.3.2 China Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        8.3.3 Japan Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        8.3.4 South Korea Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        8.3.5 India Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        8.3.7 Australia Treatments for Alpha-1 Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Treatments for Alpha-1 Consumption Value by Indication (2018-2029)
    9.2 South America Treatments for Alpha-1 Consumption Value by Application (2018-2029)
    9.3 South America Treatments for Alpha-1 Market Size by Country
        9.3.1 South America Treatments for Alpha-1 Consumption Value by Country (2018-2029)
        9.3.2 Brazil Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        9.3.3 Argentina Treatments for Alpha-1 Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Treatments for Alpha-1 Consumption Value by Indication (2018-2029)
    10.2 Middle East & Africa Treatments for Alpha-1 Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Treatments for Alpha-1 Market Size by Country
        10.3.1 Middle East & Africa Treatments for Alpha-1 Consumption Value by Country (2018-2029)
        10.3.2 Turkey Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Treatments for Alpha-1 Market Size and Forecast (2018-2029)
        10.3.4 UAE Treatments for Alpha-1 Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Treatments for Alpha-1 Market Drivers
    11.2 Treatments for Alpha-1 Market Restraints
    11.3 Treatments for Alpha-1 Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Treatments for Alpha-1 Industry Chain
    12.2 Treatments for Alpha-1 Upstream Analysis
    12.3 Treatments for Alpha-1 Midstream Analysis
    12.4 Treatments for Alpha-1 Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Treatments for Alpha-1 Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?